15.8 C
New York
Monday, April 22, 2024

Crispr Whipsaws As Wall Street Eyes Its Possible Gene-Editing Blockbuster

Crispr Therapeutics (CRSP) reported its first profit in 10 quarters on Wednesday, and CRSP stock whipsawed. This is the company’s first earnings …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,336FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x